Global Generic Active Pharmaceutical Ingredients Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Generic Active Pharmaceutical Ingredients

• 1.1 Definition of Generic Active Pharmaceutical Ingredients
• 1.2 Generic Active Pharmaceutical Ingredients Segment by Type
  • 1.2.1 Global Generic Active Pharmaceutical Ingredients Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Monoclonal Antibodies
  • 1.2.3 Hormones
  • 1.2.4 Cytokines
  • 1.2.5 Fusion Proteins
  • 1.2.6 Therapeutic Enzymes
  • 1.2.7 Vaccines
  • 1.2.8 Blood Factors
• 1.3 Generic Active Pharmaceutical Ingredients Segment by Applications
  • 1.3.1 Global Generic Active Pharmaceutical Ingredients Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Oncology
  • 1.3.3 Diabetes
  • 1.3.4 Cardiovascular Disease
  • 1.3.5 CNS and Neurological Disorders
  • 1.3.6 Endocrinology
  • 1.3.7 Others
• 1.4 Global Generic Active Pharmaceutical Ingredients Overall Market
  • 1.4.1 Global Generic Active Pharmaceutical Ingredients Revenue (2014-2025)
  • 1.4.2 Global Generic Active Pharmaceutical Ingredients Production (2014-2025)
  • 1.4.3 North America Generic Active Pharmaceutical Ingredients Status and Prospect (2014-2025)
  • 1.4.4 Europe Generic Active Pharmaceutical Ingredients Status and Prospect (2014-2025)
  • 1.4.5 China Generic Active Pharmaceutical Ingredients Status and Prospect (2014-2025)
  • 1.4.6 Japan Generic Active Pharmaceutical Ingredients Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Generic Active Pharmaceutical Ingredients Status and Prospect (2014-2025)
  • 1.4.8 India Generic Active Pharmaceutical Ingredients Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Generic Active Pharmaceutical Ingredients
• 2.3 Manufacturing Process Analysis of Generic Active Pharmaceutical Ingredients
• 2.4 Industry Chain Structure of Generic Active Pharmaceutical Ingredients

3 Development and Manufacturing Plants Analysis of Generic Active Pharmaceutical Ingredients

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Generic Active Pharmaceutical Ingredients Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Generic Active Pharmaceutical Ingredients
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Generic Active Pharmaceutical Ingredients Production and Capacity Analysis
• 4.2 Generic Active Pharmaceutical Ingredients Revenue Analysis
• 4.3 Generic Active Pharmaceutical Ingredients Price Analysis
• 4.4 Market Concentration Degree

5 Generic Active Pharmaceutical Ingredients Regional Market Analysis

• 5.1 Generic Active Pharmaceutical Ingredients Production by Regions
  • 5.1.1 Global Generic Active Pharmaceutical Ingredients Production by Regions
  • 5.1.2 Global Generic Active Pharmaceutical Ingredients Revenue by Regions
• 5.2 Generic Active Pharmaceutical Ingredients Consumption by Regions
• 5.3 North America Generic Active Pharmaceutical Ingredients Market Analysis
  • 5.3.1 North America Generic Active Pharmaceutical Ingredients Production
  • 5.3.2 North America Generic Active Pharmaceutical Ingredients Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Generic Active Pharmaceutical Ingredients Import and Export
• 5.4 Europe Generic Active Pharmaceutical Ingredients Market Analysis
  • 5.4.1 Europe Generic Active Pharmaceutical Ingredients Production
  • 5.4.2 Europe Generic Active Pharmaceutical Ingredients Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Generic Active Pharmaceutical Ingredients Import and Export
• 5.5 China Generic Active Pharmaceutical Ingredients Market Analysis
  • 5.5.1 China Generic Active Pharmaceutical Ingredients Production
  • 5.5.2 China Generic Active Pharmaceutical Ingredients Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Generic Active Pharmaceutical Ingredients Import and Export
• 5.6 Japan Generic Active Pharmaceutical Ingredients Market Analysis
  • 5.6.1 Japan Generic Active Pharmaceutical Ingredients Production
  • 5.6.2 Japan Generic Active Pharmaceutical Ingredients Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Generic Active Pharmaceutical Ingredients Import and Export
• 5.7 Southeast Asia Generic Active Pharmaceutical Ingredients Market Analysis
  • 5.7.1 Southeast Asia Generic Active Pharmaceutical Ingredients Production
  • 5.7.2 Southeast Asia Generic Active Pharmaceutical Ingredients Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Generic Active Pharmaceutical Ingredients Import and Export
• 5.8 India Generic Active Pharmaceutical Ingredients Market Analysis
  • 5.8.1 India Generic Active Pharmaceutical Ingredients Production
  • 5.8.2 India Generic Active Pharmaceutical Ingredients Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Generic Active Pharmaceutical Ingredients Import and Export

6 Generic Active Pharmaceutical Ingredients Segment Market Analysis (by Type)

• 6.1 Global Generic Active Pharmaceutical Ingredients Production by Type
• 6.2 Global Generic Active Pharmaceutical Ingredients Revenue by Type
• 6.3 Generic Active Pharmaceutical Ingredients Price by Type

7 Generic Active Pharmaceutical Ingredients Segment Market Analysis (by Application)

• 7.1 Global Generic Active Pharmaceutical Ingredients Consumption by Application
• 7.2 Global Generic Active Pharmaceutical Ingredients Consumption Market Share by Application (2014-2019)

8 Generic Active Pharmaceutical Ingredients Major Manufacturers Analysis

• 8.1 Pfizer, Inc. (U.S.)
  • 8.1.1 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 8.1.2 Pfizer, Inc. (U.S.) Product Introduction, Application and Specification
  • 8.1.3 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Novartis International AG (Switzerland)
  • 8.2.1 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 8.2.2 Novartis International AG (Switzerland) Product Introduction, Application and Specification
  • 8.2.3 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Sanofi (France)
  • 8.3.1 Sanofi (France) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 8.3.2 Sanofi (France) Product Introduction, Application and Specification
  • 8.3.3 Sanofi (France) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Boehringer Ingelheim (Germany)
  • 8.4.1 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 8.4.2 Boehringer Ingelheim (Germany) Product Introduction, Application and Specification
  • 8.4.3 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Bristol-Myers Squibb (U.S.)
  • 8.5.1 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 8.5.2 Bristol-Myers Squibb (U.S.) Product Introduction, Application and Specification
  • 8.5.3 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Teva Pharmaceutical Industries Ltd. (Israel)
  • 8.6.1 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 8.6.2 Teva Pharmaceutical Industries Ltd. (Israel) Product Introduction, Application and Specification
  • 8.6.3 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Eli Lilly and Company (U.S.)
  • 8.7.1 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 8.7.2 Eli Lilly and Company (U.S.) Product Introduction, Application and Specification
  • 8.7.3 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 GlaxoSmithKline plc (U.K.)
  • 8.8.1 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 8.8.2 GlaxoSmithKline plc (U.K.) Product Introduction, Application and Specification
  • 8.8.3 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Merck & Co., Inc. (U.S.)
  • 8.9.1 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 8.9.2 Merck & Co., Inc. (U.S.) Product Introduction, Application and Specification
  • 8.9.3 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 AbbVie Inc. (U.S.)
  • 8.10.1 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production Sites and Area Served
  • 8.10.2 AbbVie Inc. (U.S.) Product Introduction, Application and Specification
  • 8.10.3 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Generic Active Pharmaceutical Ingredients Market

• 9.1 Global Generic Active Pharmaceutical Ingredients Market Trend Analysis
  • 9.1.1 Global Generic Active Pharmaceutical Ingredients Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Generic Active Pharmaceutical Ingredients Regional Market Trend
  • 9.2.1 North America Generic Active Pharmaceutical Ingredients Forecast 2019-2025
  • 9.2.2 Europe Generic Active Pharmaceutical Ingredients Forecast 2019-2025
  • 9.2.3 China Generic Active Pharmaceutical Ingredients Forecast 2019-2025
  • 9.2.4 Japan Generic Active Pharmaceutical Ingredients Forecast 2019-2025
  • 9.2.5 Southeast Asia Generic Active Pharmaceutical Ingredients Forecast 2019-2025
  • 9.2.6 India Generic Active Pharmaceutical Ingredients Forecast 2019-2025
• 9.3 Generic Active Pharmaceutical Ingredients Market Trend (Product Type)
• 9.4 Generic Active Pharmaceutical Ingredients Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Generic Active Pharmaceutical Ingredients Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List